Yong Jun Jeon
Yong Jun Jeon has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Dong Woo Shin
Department of Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea
1 shared publication - Eui Chul Jeong
Colonoscopy Study Group, The Korean Society of Coloproctology, Seoul, Korea
1 shared publication - Jong Wan Kim
Department of Surgery, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong-Si, Gyeonggi-Do, Republic of Korea
1 shared publication - SungGil Park
Department of Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea
1 shared publication
Latest Publications
- Open Access
- 15 March 2021
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 24 (1) , 51-55
Laparoscopic duodenal segmental resection and duodenojejunostomy for symptomatic duodenal diverticula in three cases treated at a community hospital
The duodenum is the second most common site of diverticula following the colon, but is associated with fewer complications than colonic diverticula. Diverticulitis, cholangitis, pancreatitis, perforation, hemorrhage, and blind loop syndrome may occur as complications of duodenal diverticula. Although nonoperative treatment is an option for patients in good condition without signs of sepsis, surgery is generally required for definitive treatment of complications. There are several surgical procedures for symptomatic duodenal diverticula. We performed laparoscopic duodenal segmental resection and duodenojejunostomy without open conversion in three cases. We believe that this procedure is ideal for cases of symptomatic duodenal diverticula when performed by an experienced surgeon with the goal of definitive treatment.
- 15 March 2021
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 24 (1) , 51-55
Open AccessLaparoscopic duodenal segmental resection and duodenojejunostomy for symptomatic duodenal diverticula in three cases treated at a community hospital
The duodenum is the second most common site of diverticula following the colon, but is associated with fewer complications than colonic diverticula. Diverticulitis, cholangitis, pancreatitis, perforation, hemorrhage, and blind loop syndrome may occur as complications of duodenal diverticula. Although nonoperative treatment is an option for patients in good condition without signs of sepsis, surgery is generally required for definitive treatment of complications. There are several surgical procedures for symptomatic duodenal diverticula. We performed laparoscopic duodenal segmental resection and duodenojejunostomy without open conversion in three cases. We believe that this procedure is ideal for cases of symptomatic duodenal diverticula when performed by an experienced surgeon with the goal of definitive treatment.
- Open Access
- 30 November 2019
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 34 (4) , 269-275
Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study
Snakebite can cause various complications, including coagulopathy. The clinical features of snakebite-associated coagulopathy differ from those of disseminated intravascular coagulation (DIC) caused by other diseases and its treatment is controversial. We retrospectively reviewed the medical records of patients hospitalized for snakebite between January 2006 and September 2018. A total of 226 patients were hospitalized due to snakebite. Their median hospital stay was 4.0 days (interquartile range, 2.0 to 7.0 days). Five patients arrived at hospital with shock and one patient died. Twenty-one patients had overt DIC according to the International Society of Thrombosis and Hemostasis scoring system. Two patients developed major bleeding complications. Initial lower cholesterol level at presentation was associated with the development of overt DIC. International normalization ratio (INR) exceeding the laboratory's measurement limit was recorded as late as 4 to 5 days after the bite. Higher antivenom doses (≥18,000 units) and transfusion of fresh frozen plasma (FFP) or cryoprecipitate did not affect prolonged INR duration or hospital stay in the overt DIC patients without bleeding. Initial lower cholesterol level may be a risk factor for overt DIC following snakebite. Although patients lack apparent symptoms, the risk of coagulopathy should be assessed for at least 4 to 5 days following snakebite. Higher antivenom doses and transfusion of FFP or cryoprecipitate may be unbeneficial for coagulopathic patients without bleeding.
- 30 November 2019
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 34 (4) , 269-275
Open AccessRisk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study
Snakebite can cause various complications, including coagulopathy. The clinical features of snakebite-associated coagulopathy differ from those of disseminated intravascular coagulation (DIC) caused by other diseases and its treatment is controversial. We retrospectively reviewed the medical records of patients hospitalized for snakebite between January 2006 and September 2018. A total of 226 patients were hospitalized due to snakebite. Their median hospital stay was 4.0 days (interquartile range, 2.0 to 7.0 days). Five patients arrived at hospital with shock and one patient died. Twenty-one patients had overt DIC according to the International Society of Thrombosis and Hemostasis scoring system. Two patients developed major bleeding complications. Initial lower cholesterol level at presentation was associated with the development of overt DIC. International normalization ratio (INR) exceeding the laboratory's measurement limit was recorded as late as 4 to 5 days after the bite. Higher antivenom doses (≥18,000 units) and transfusion of fresh frozen plasma (FFP) or cryoprecipitate did not affect prolonged INR duration or hospital stay in the overt DIC patients without bleeding. Initial lower cholesterol level may be a risk factor for overt DIC following snakebite. Although patients lack apparent symptoms, the risk of coagulopathy should be assessed for at least 4 to 5 days following snakebite. Higher antivenom doses and transfusion of FFP or cryoprecipitate may be unbeneficial for coagulopathic patients without bleeding.